Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | USP2 | O75604 | 3/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.58 |
| ▸ | BLM | P54132 | 3/20 | 0.58 |
| ▸ | RECQL | P46063 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | THPO | P40225 | 2/20 | 0.58 |
| ▸ | PKM | P14618 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29216329 | 1.00 | KDM4E (0.58) | KDM4EHSD17B10ALDH1A1LMNAMAPT | |
| SCHEMBL5287555 | 0.84 | KDM4E (0.53) | KDM4EHSD17B10ALDH1A1LMNAMAPT | |
| SCHEMBL5284385 | 0.84 | KDM4E (0.53) | KDM4EHSD17B10ALDH1A1LMNAMAPT | |
| SCHEMBL6046185 | 0.84 | KDM4E (0.57) | KDM4EHSD17B10ALDH1A1LMNAMAPT | |
| SCHEMBL3467175 | 0.84 | SLC7A5 (0.54) | KDM4EHSD17B10ALDH1A1LMNAMAPT | |
| SCHEMBL3467173 | 0.84 | SLC7A5 (0.54) | KDM4EHSD17B10ALDH1A1LMNAMAPT | |
| SCHEMBL1700767 | 0.84 | KDM4E (0.56) | KDM4EHSD17B10ALDH1A1LMNAMAPT | |
| SCHEMBL29540097 | 0.84 | KDM4E (0.56) | KDM4EHSD17B10ALDH1A1LMNAMAPT | |
| SCHEMBL157790 | 0.84 | KDM4E (0.56) | KDM4EHSD17B10ALDH1A1LMNAMAPT | |
| SCHEMBL27751535 | 0.83 | KDM4E (0.49) | KDM4EHSD17B10ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270429-A1 | PROTEIN-BASED ADHESIVE AND ITS MODIFICATION | PURDUE RESEARCH FOUNDATION (US) | 2025-08-28 | — | — | US | claimed |
| US-12331230-B2 | Protein-based adhesive and its modification | PURDUE RESEARCH FOUNDATION | 2025-06-17 | — | — | US | claimed |
| CN-117925336-A | Cleaning liquid after chemical mechanical polishing and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2023128791-A1 | COMBINATION DRUG FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ЦЕНТР РАННЕЙ ДИАГНОСТИКИ НЕЙРОДЕГЕНЕРАТИВНЫХ ЗАБОЛЕВАНИЙ" | 2023-07-06 | — | — | WO | claimed |
| US-20210207013-A1 | PROTEIN-BASED ADHESIVE AND ITS MODIFICATION | PURDUE RESEARCH FOUNDATION (US) | 2021-07-08 | — | — | US | claimed |
| WO-2020041557-A1 | PROTEIN-BASED ADHESIVE AND ITS MODIFICATION | PURDUE RESEARCH FOUNDATION (US) | 2020-02-27 | — | — | WO | claimed |
| US-20190201349-A1 | CAPSULES AND PARTICLES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-07-04 | — | — | US | claimed |
| WO-2017072759-A1 | CAPSULES AND PARTICLES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2017-05-04 | — | — | WO | claimed |
| EP-2306192-B1 | Risk Markers For Cardiovascular Disease | CLEVELAND CLINIC FOUNDATION (US) | 2015-10-14 | — | — | EP | claimed |
| US-9005904-B2 | Risk markers for cardiovascular disease | THE CLEVELAND CLINIC FOUNDATION (US) | 2015-04-14 | — | — | US | claimed |
| WO-2009114875-A2 | OXIDIZED PARAOXONASE 1 AND PARAOXONASE 1/HDL PARTICLE NUMBER RATIO AS RISK MARKERS FOR CARDIOVASCULAR DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2009-09-17 | — | — | WO | claimed |
| CN-101384545-A | Deuterated catecholamine derivatives and medicaments comprising said compounds | BIRDS PHARMA GMBH BEROLINA INN (DE) | 2009-03-11 | — | — | CN | claimed |
| US-7427690-B2 | Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration | BIODERM RESEARCH (US) | 2008-09-23 | — | — | US | claimed |
| EP-1697746-A4 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | CLEVELAND CLINIC FOUNDATION (US) | 2007-08-29 | — | — | EP | claimed |
| US-20070099886-A1 | Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration | BIODERM RESEARCH (US) | 2007-05-03 | — | — | US | claimed |
| EP-1697746-A2 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | The Cleveland Clinic Foundation (US) | 2006-09-06 | — | — | EP | claimed |
| US-20050239136-A1 | Risk markers for cardiovacular disease | THE CLEVELAND CLINIC FOUNDATION | 2005-10-27 | — | — | US | claimed |
| WO-2005055810-A2 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2005-06-23 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-5047344-A | Alteromonas Bacteria To Attract Oyster Larvae | RESEARCH CORPORATION TECHNIQUES, INC. (US) | 1991-09-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190201349-A1 | CAPSULES AND PARTICLES AND USES THEREOF | ALG1, LPO, FUT5 | KDM4E 4642/4885HSD17B10 3106/4885ALDH1A1 1287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.